Tyler Bussian

Stock Analyst at Brookline Capital

(1.76)

# 1,808

Out of 4,414 analysts

3

Total ratings

50%

Success rate

56.55%

Average return

Main Sectors:

Top Industries:

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	IMUX Immunic	Initiates: Buy	$10	$1.30	+669.23%	1	Apr 5, 2024
	ANVS Annovis Bio	Downgrades: Hold	$9	$6.11	+47.30%	2	Feb 28, 2024

Immunic

Apr 5, 2024

Initiates: Buy

Price Target: $10

Current: $1.30

Upside: +669.23%

Annovis Bio

Feb 28, 2024

Downgrades: Hold

Price Target: $9

Current: $6.11

Upside: +47.30%